We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LI:NASDAQLi Auto Inc. Analysis

Data as of 2026-06-07 - not real-time

$14.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Li Auto (LI) is trading at $14.20, well below its 20‑day ($16.52), 50‑day ($17.52) and 200‑day ($19.26) simple moving averages, signaling a pronounced bearish technical stance. The RSI of 29.9 places the stock in oversold territory, while a bearish MACD histogram (-0.196) and a support level at $14.06 suggest limited upside in the near term. Despite a forward P/E of 13.8 and an ultra‑low price‑to‑sales multiple of 0.13, the company posted a 11.4% revenue decline year‑over‑year, a gross margin of only 15.9% (further eroded to 7.9% in Q1 2026), and a net loss of RMB 2.3 bn, with negative operating and free cash flow. The balance sheet remains strong with $93 bn in cash versus $17.7 bn debt, but the debt‑to‑equity ratio of 25% and a 55% 30‑day volatility underscore financial strain.
The launch of the all‑new Li L9 and sustained deliveries of over 20,000 i6 units per month have reignited sales growth, with Q2 deliveries projected at 95‑100 k vehicles and May deliveries reaching 33,350 units. Analyst consensus remains bullish (27 analysts, “Buy” rating) and target prices average $18.8, implying ~32% upside. However, the sector’s cyclical nature, heightened regulatory scrutiny in China’s EV market, and the company’s ongoing margin compression temper enthusiasm. Investors should weigh the undervalued valuation against the high volatility, negative cash flows, and medium‑to‑high geographic and regulatory risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support at $14.06
  • Oversold RSI indicating potential short‑term bounce
  • Weak profitability and negative cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Launch of the Li L9 expanding product lineup
  • Improving delivery volumes (95k+ Q2 guidance)
  • Undervalued valuation metrics (P/S 0.13, forward P/E 13.8)

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term growth of China’s EV market
  • Strong cash position offsetting debt load
  • Analyst consensus upside of ~30% to target price

Key Metrics & Analysis

Financial Health

Revenue Growth-11.40%
Profit Margin-1.66%
P/E Ratio13.8
ROE-2.50%
ROA-1.51%
Debt/Equity25.12
P/B Ratio1.4
Op. Cash Flow$-13001422848
Free Cash Flow$-15601390592

Technical Analysis

TrendBearish
RSI29.9
Support$14.06
Resistance$20.09
MA 20$16.52
MA 50$17.52
MA 200$19.26
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Target Price$18.78
Upside/Downside32.28%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.99
Volatility50.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.